These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22029758)

  • 1. One man at a time--resolving the PSA controversy.
    McNaughton-Collins MF; Barry MJ
    N Engl J Med; 2011 Nov; 365(21):1951-3. PubMed ID: 22029758
    [No Abstract]   [Full Text] [Related]  

  • 2. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
    Schröder FH
    N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
    Brett AS; Ablin RJ
    N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
    Kwiatkowski M; Klotz L; Hugosson J; Recker F
    Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
    [No Abstract]   [Full Text] [Related]  

  • 5. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.
    Messing EM; Albertsen P; Andriole GL; Carroll PR; Klein EA
    Urol Oncol; 2012; 30(1):117-9. PubMed ID: 22243597
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
    Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
    Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer. When to offer screening in the primary care setting.
    Gambert SR
    Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
    Volk RJ; Wolf AM
    JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
    [No Abstract]   [Full Text] [Related]  

  • 9. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.
    Ablin RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):391-4. PubMed ID: 22315362
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for prostate cancer among men 75 years of age or older.
    Barry MJ
    N Engl J Med; 2008 Dec; 359(24):2515-6. PubMed ID: 19073973
    [No Abstract]   [Full Text] [Related]  

  • 11. The pendulum swings back: Screening for prostate cancer in 2018.
    Thompson IM
    Cancer; 2018 Jul; 124(13):2690-2692. PubMed ID: 29786846
    [No Abstract]   [Full Text] [Related]  

  • 12. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening.
    Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D
    Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 15. Missing the mark on prostate-specific antigen screening.
    Miller DC; Hollenbeck BK
    JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
    [No Abstract]   [Full Text] [Related]  

  • 16. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
    Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
    Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological research and the prostate-cancer screening controversy.
    Arkes HR; Gaissmaier W
    Psychol Sci; 2012 Jun; 23(6):547-53. PubMed ID: 22555966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 19. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 20. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
    Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
    Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.